However, in the presence of stable knockout of CDK12 activity, it is likely that a few surviving cancer cells accumulate large genomic aberrations that may ultimately create new oncogenes and generate a highly resistant phenotype, as observed in advanced prostate cancer. Here, CDK12 is linked to cancer.